The drug Gefitinib showed high results in the treatment of patients with non-small cell lung cancer with metastases in the brain. Effective in the fight against malignant tumors of the lungs and bronchi, namely metastatic or local lung cancer that is resistant to traditional chemotherapy containing docetaxel or platinum derivatives. This anticancer drug allows you to achieve complete regression, partial, as well as stabilization of the disease. Gefitinib inhibits tumor cell proliferation, metastasis and apoptosis, has an objective effect on cancer cells and delays disease progression in patients with localized lung cancer or NSCLC.
Active substance: gefitinib